COMMUNIQUÉS West-GlobeNewswire

Tonix Pharmaceuticals Expands Intellectual Property Portfolio for TNX-102 SL
21/03/2018
U.S. Patent Issued Covering the Use of Tonmya® (Cyclobenzaprine HCl Sublingual Tablets) for treating Posttraumatic Stress Disorder (PTSD) Patent Will Provide Intellectual Property Protection until at least 2030 for Use [...]
Aeterna Zentaris to Announce Fourth Quarter and Year End 2017 Financial and Operating Results on March 28th, 2018
21/03/2018
CHARLESTON, S.C., March 21, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) will announce its fourth quarter and year ended December 31, 2017 financial and operating results after market [...]
Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Full Year 2017 Financial Results and Business Updates
21/03/2018
CAMBRIDGE, Mass., March 21, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN ), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]
Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Full Year 2017 Financial Results and Business Updates
21/03/2018
CAMBRIDGE, Mass., March 21, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN ), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]
Solon Eiendom ASA : Primary insider notification
21/03/2018
(Oslo, Norway, 21 March 2018) Per Knut Asphaug Bernhardt, personal assistant to the chairman of the board of Solon Eiendom ASA, (through his wholly owned company Factum AS) has today rolled over a forward contract for [...]
Sport Endurance Wholly-Owned Subsidiary, Yield Endurance, Enters into Strategic Partnership with Madison Partners
21/03/2018
JERSEY CITY, N.J., March 21, 2018 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTCQB:SENZ) (the “Company”) wholly-owned subsidiary, Yield Endurance, Inc., today announced entering into a strategic partnership and [...]
HealthLynked Corp. Announces Dr. Michael Dent, CEO is presenting at the NIBA New York Conference on March 27, 2018
21/03/2018
NAPLES, Fla., March 21, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK) today announced that Dr. Michael Dent, its Chief Executive Officer, is presenting at the National Investment Bankers Association (NIBA). [...]
FIT Biotech Oy: FIT Biotech Oy converts Convertible Capital Notes into shares and exceeds the authorization granted in the Extraordinary General Meeting on February 6, 2018
21/03/2018
FIT Biotech Oy Company release March 21, 2018 at 03:30 PM EET FIT Biotech Oy converts Convertible Capital Notes into shares and exceeds the authorization granted in the Extraordinary General Meeting on February 6, 2018 [...]
ProPhase Labs Reports Financial Results for the Year Ended December 31, 2017
21/03/2018
DOYLESTOWN, Pa., March 21, 2018 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH ), ( www.ProPhaseLabs.com ) today reported its net sales from continuing operations were $9.9 million for the year ended December 31 [...]
Immunicum AB: Invitation to Investor Events
21/03/2018
Press Release 21 March 2018 Immunicum AB: Invitation to Investor Events Immunicum AB (publ; IMMU.ST) a biopharmaceutical company advancing a novel, immune-priming cancer treatment against a variety of solid tumors, [...]
NewLink Genetics Appoints Chad A. Johnson to Board of Directors
21/03/2018
AMES, Iowa, March 21, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) today announced the appointment of Chad A. Johnson, 39, to the Company's Board of Directors. In connection with this [...]
AXIM Biotech to Attend BioCentury’s 25th Annual Future Leaders in the Biotech Industry Conference in New York
21/03/2018
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (AXIM ® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George E. Anastassov, MD, DDS, MBA and [...]
Devonian Announces Grant of Options
21/03/2018
QUEBEC CITY, March 21, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. (" Devonian " or the " Corporation ") (TSX VENTURE:GSD) announces that the Board of Directors has approved the grant of options (the ‘‘Options [...]
Devonian annonce l’octroi d’options
21/03/2018
QUÉBEC, 21 mars 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian Inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD) annonce que le conseil d'administration a approuvé l'octroi d'options (les «options») pour [...]
Aquinox to Present at the 17th Annual Needham Healthcare Conference
21/03/2018
VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to [...]
Scapa Healthcare Starts Construction on New Medical Device Manufacturing Facility in Knoxville, TN
21/03/2018
WINDSOR, Conn., March 21, 2018 (GLOBE NEWSWIRE) -- Scapa Healthcare , a trusted strategic outsource partner of skin-friendly, turnkey solutions for advanced wound care, medical device and consumer wellness markets, is [...]
SELLAS Life Sciences Announces Appointment of Barbara A. Wood as Executive Vice President, General Counsel and Corporate Secretary
21/03/2018
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc., (Nasdaq: SLS ) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer [...]
Allovate Therapeutics Announces Issuance of Second Japanese Patent, Expanding Global Coverage of the Oral Mucosal Immunotherapy Platform
21/03/2018
New York, March 21, 2018 (GLOBE NEWSWIRE) -- Allovate Therapeutics, a biopharmaceutical company focused on improving treatment options for allergies, announced today that the Japan Patent Office (JPO) has recently [...]
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with CellBridge Incorporated
21/03/2018
MINNEAPOLIS, March 21, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical, announced today that its wholly owned subsidiary, TumorGenesis Inc., [...]

Pages